Health Care [ 12/12 ] | Biotechnology [ 62/74 ]
NASDAQ | Common Stock
Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets.
Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 13, 24 | -0.07 Increased by +90.09% | - |
| Jun 17, 24 | -0.61 Decreased by -114.82% | - |
| Mar 7, 24 | -0.17 Increased by +83.47% | - |
| Nov 16, 23 | -0.61 Increased by +63.40% | - |
| Aug 11, 23 | -0.70 Increased by +66.67% | - |
| Mar 27, 23 | 4.10 Increased by +191.11% | -0.19 Increased by +2.26 K% |
| Nov 14, 22 | -1.04 Increased by +87.16% | -0.90 Decreased by -15.56% |
| Aug 15, 22 | -1.66 Increased by +65.42% | -1.20 Decreased by -38.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 0.00 Decreased by -100.00% | -600.00 K Increased by +89.59% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 500.00 K Increased by +N/A% | -829.00 K Increased by +81.19% | Decreased by -165.80% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by -100.00% | -1.49 M Decreased by -108.08% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by -100.00% | -5.26 M Decreased by -1.86% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 2.47 M Increased by 0.00% | -5.76 M Increased by +22.84% | Decreased by -233.27% Increased by +22.84% |
| Mar 31, 23 | 0.00 Decreased by -100.00% | -4.41 M Increased by +47.21% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 21.77 M Increased by +928.05% | 18.40 M Increased by +233.06% | Increased by +84.49% Increased by +112.94% |
| Sep 30, 22 | 2.02 M Increased by +154.83% | -5.16 M Increased by +78.07% | Decreased by -255.95% Decreased by -140.00% |